查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595231

患者血液管理市场：按产品、组件和最终用户划分 - 全球预测 2025-2030 年

Patient Blood Management Market by Product (Accessories, Instrument, Reagent & Kit), Component (Plasma, Whole Blood & Red Blood Cell), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年患者血液管理市场价值为 158.5 亿美元，预计到 2024 年将达到 171.7 亿美元，复合年增长率为 8.00%，到 2030 年将达到 271.7 亿美元。

患者血液管理 (PBM) 是一种多学科、基于证据的方法，用于优化可能需要输血的患者的护理。 PBM 的范围包括减少不必要的输血、最大限度地减少出血以及根据患者个体需求量身定制的特定策略来改善患者的治疗结果。这种方法对于解决医疗机构中血液供不应求、输血相关併发症和成本控制的挑战至关重要。 PBM 在外科、肿瘤学、创伤护理和慢性病管理等各个医疗领域都有应用，医院、诊所和血库是主要的最终使用者。市场成长受到慢性病和外科疾病盛行率上升、输血风险意识不断增强以及细胞拯救和血液替代等技术进步的影响。鼓励实施 PBM 的法律规范将进一步刺激市场扩张。透过投资增强血液储存、自动化资料收集和实现个人化医疗的技术来抓住市场机会。非侵入性血红素监测和新型红血球生成刺激因子製剂的开发也带来了机会。然而，实施成本高、缺乏意识以及不愿偏离传统输血做法等挑战正在阻碍市场成长。研究、开发和创新可以集中于开发具有成本效益的 PBM 解决方案和教育计划，以提高认知度和采用率。分析 PBM 实施后的患者结果可以提供有关疗效和安全性的宝贵资料，并吸引更多的医疗保健提供者。 PBM 市场的本质是动态的，受到技术进步和监管变化的驱动。成功应对这一情况需要相关人员掌握新兴趋势，促进合作，并积极应对血液滥用和稀缺挑战，以改善业务成果，同时改善患者护理和安全。

主要市场统计
基准年[2023] 158.5亿美元
预测年份 [2024] 171亿美元
预测年份 [2030] 271.7亿美元
复合年增长率（%） 8.00%

市场动态：快速发展的患者血液管理市场的关键市场洞察

供需的动态交互作用正在改变患者血液管理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 血液疾病急剧增加导致交通事故增加，需要血液管理
    • 各种患者血液管理指南的可用性
    • 政府鼓励捐血的倡议
  • 市场限制因素
    • 自动化系统高成本
  • 市场机会
    • 患者血液管理的技术进步
    • 先进血液储存和输血设备的开发
  • 市场挑战
    • 医护人员短缺

波特五力：驾驭病患血液管理市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解患者血液管理市场的外部影响

外部宏观环境因素在塑造患者血液管理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解病患血液管理市场的竞争状况

患者血液管理市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵病患血液管理市场供应商的绩效评估

FPNV 定位矩阵是评估病患血液管理市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划患者血液管理市场的成功之路

患者血液管理市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于血液疾病的蔓延导致交通事故增加，因此需要进行血液管理
      • 各种患者血液管理指南的可用性
      • 政府鼓励捐血的倡议
    • 抑制因素
      • 自动化系统高成本
    • 机会
      • 患者血液管理的技术进步
      • 先进血液储存及输血设备的研发
    • 任务
      • 医护人员短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章病患血液管理市场：副产品

  • 配件
    • 血袋
    • 注射器和针头
    • 管瓶和管
  • 装置
    • 血液培养检测装置
      • 自动血液培养系统
      • 实验室设备支援
    • 血液处理设备
      • 血球处理设备
      • 离心机
    • 血液储存装置
      • 医用冷冻库
      • 医用冰箱
    • 输血装置
      • 血浆分离装置
      • 细胞救援系统
      • 血浆及血浆成分分离设备
    • 诊断和测试设备
      • 血型分析仪
      • 血液分析仪
      • NGS平台
      • PCR装置
  • 试剂和套件
    • 检测试剂套件
    • 血培养基
    • 血型测定试剂
    • 玻片染色试剂
  • 软体
    • 血库管理软体
    • 输血管理软体

第七章患者血液管理市场：依组成部分

  • 电浆
  • 全血和红血球

第八章患者血液管理市场：依最终用户分类

  • 血库
  • 诊断诊所和病理实验室
  • 医院

第九章美洲患者血液管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太患者血液管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的病患血液管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • LivaNova, Inc.
  • Macopharma, Inc.
  • Merck & Co., Inc.
  • Terumo Corporation
Product Code: MRR-0372549B1FF1

The Patient Blood Management Market was valued at USD 15.85 billion in 2023, expected to reach USD 17.10 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 27.17 billion by 2030.

Patient Blood Management (PBM) is a multidisciplinary, evidence-based approach to optimizing the care of patients who might need transfusion. The scope of PBM involves reducing unnecessary transfusions, minimizing blood loss, and improving patient outcomes through specific strategies tailored to individual patient needs. This approach is essential as it addresses the challenges of blood supply shortages, transfusion-related complications, and cost containment in healthcare settings. PBM is applied in various medical fields, including surgery, oncology, trauma care, and chronic disease management, with hospitals, clinics, and blood banking institutions serving as primary end-users. Market growth is influenced by the rising prevalence of chronic and surgical conditions, increasing awareness about the risks of transfusion, and advances in technologies such as cell salvage and blood substitutes. Regulatory frameworks encouraging PBM practices further spur market expansion. Opportunities in the market can be seized by investing in technologies that enhance blood conservation, automate data collection, and enable personalized medicine. The development of non-invasive hemoglobin monitoring and new erythropoiesis-stimulating agents also presents opportunities. However, challenges such as high implementation costs, lack of awareness, and reluctance to deviate from traditional transfusion practices impede market growth. Research and innovation can focus on developing cost-effective PBM solutions and educational programs to increase awareness and adoption. Analyzing patient outcomes post-PBM implementation can provide valuable data on efficacy and safety, attracting more healthcare providers to the practice. The nature of the PBM market is dynamic, propelled by technological advancements and regulatory changes. Successfully navigating this landscape requires stakeholders to stay informed on emerging trends, foster collaborations, and proactively address the challenges of blood misuse and scarcity, ensuring business growth while enhancing patient care and safety.

KEY MARKET STATISTICS
Base Year [2023] USD 15.85 billion
Estimated Year [2024] USD 17.10 billion
Forecast Year [2030] USD 27.17 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Blood Management Market

The Patient Blood Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
    • Availability of various patient blood management guidelines
    • Government initiatives encouraging blood donations
  • Market Restraints
    • High cost of the automated systems
  • Market Opportunities
    • Technology advancements in the patient blood management
    • Development of advanced blood storage and blood transfusion devices
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Patient Blood Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Blood Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Patient Blood Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Blood Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Patient Blood Management Market

A detailed market share analysis in the Patient Blood Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Blood Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Blood Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Patient Blood Management Market

A strategic analysis of the Patient Blood Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Patient Blood Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Bio-Rad Laboratories, Inc., Biomerieux SA, Danaher Corporation, F. Hoffmann-La Roche LTD., Fresenius Se & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Immucor, Inc., LivaNova, Inc., Macopharma, Inc., Merck & Co., Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Patient Blood Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Instrument, Reagent & Kit, and Software. The Accessories is further studied across Blood Bag, Syringe & Needle, and Vial & Tube. The Instrument is further studied across Blood Culture Screening Device, Blood Processing Device, Blood Storage Device, Blood Transfusion Device, and Diagnostic & Testing Instrument. The Blood Culture Screening Device is further studied across Automated Blood Culture System and Supporting Laboratory Equipment. The Blood Processing Device is further studied across Blood Cell Processor and Centrifuges. The Blood Storage Device is further studied across Medical Freezer and Medical Refrigerator. The Blood Transfusion Device is further studied across Apheresis Machine, Cell Salvage System, and Plasma & Plasma Component Separator. The Diagnostic & Testing Instrument is further studied across Blood Grouping Analyzer, Hematology Analyzer, NGS Platform, and PCR Instrument. The Reagent & Kit is further studied across Assay Kit, Blood Culture Media, Blood Typing Reagent, and Slide Staining Reagent. The Software is further studied across Blood Bank Management Software and Transfusion Management Software.
  • Based on Component, market is studied across Plasma and Whole Blood & Red Blood Cell.
  • Based on End User, market is studied across Blood Bank, Diagnostic Clinic & Pathology Lab, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
      • 5.1.1.2. Availability of various patient blood management guidelines
      • 5.1.1.3. Government initiatives encouraging blood donations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the automated systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology advancements in the patient blood management
      • 5.1.3.2. Development of advanced blood storage and blood transfusion devices
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Patient Blood Management Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Blood Bag
    • 6.2.2. Syringe & Needle
    • 6.2.3. Vial & Tube
  • 6.3. Instrument
    • 6.3.1. Blood Culture Screening Device
      • 6.3.1.1. Automated Blood Culture System
      • 6.3.1.2. Supporting Laboratory Equipment
    • 6.3.2. Blood Processing Device
      • 6.3.2.1. Blood Cell Processor
      • 6.3.2.2. Centrifuges
    • 6.3.3. Blood Storage Device
      • 6.3.3.1. Medical Freezer
      • 6.3.3.2. Medical Refrigerator
    • 6.3.4. Blood Transfusion Device
      • 6.3.4.1. Apheresis Machine
      • 6.3.4.2. Cell Salvage System
      • 6.3.4.3. Plasma & Plasma Component Separator
    • 6.3.5. Diagnostic & Testing Instrument
      • 6.3.5.1. Blood Grouping Analyzer
      • 6.3.5.2. Hematology Analyzer
      • 6.3.5.3. NGS Platform
      • 6.3.5.4. PCR Instrument
  • 6.4. Reagent & Kit
    • 6.4.1. Assay Kit
    • 6.4.2. Blood Culture Media
    • 6.4.3. Blood Typing Reagent
    • 6.4.4. Slide Staining Reagent
  • 6.5. Software
    • 6.5.1. Blood Bank Management Software
    • 6.5.2. Transfusion Management Software

7. Patient Blood Management Market, by Component

  • 7.1. Introduction
  • 7.2. Plasma
  • 7.3. Whole Blood & Red Blood Cell

8. Patient Blood Management Market, by End User

  • 8.1. Introduction
  • 8.2. Blood Bank
  • 8.3. Diagnostic Clinic & Pathology Lab
  • 8.4. Hospital

9. Americas Patient Blood Management Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Patient Blood Management Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Patient Blood Management Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asahi Kasei Medical Co. Ltd.
  • 3. B. Braun Melsungen AG
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux SA
  • 6. Danaher Corporation
  • 7. F. Hoffmann-La Roche LTD.
  • 8. Fresenius Se & Co. KGaA
  • 9. Grifols, S.A.
  • 10. Haemonetics Corporation
  • 11. Immucor, Inc.
  • 12. LivaNova, Inc.
  • 13. Macopharma, Inc.
  • 14. Merck & Co., Inc.
  • 15. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. PATIENT BLOOD MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PATIENT BLOOD MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PATIENT BLOOD MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PATIENT BLOOD MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT PATIENT BLOOD MANAGEMENT